• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于蔻酸作用模式的机制见解。

Mechanistic Insight on the Mode of Action of Colletoic Acid.

机构信息

Department of Medicine , The University of Tennessee Health Science Center , Memphis , Tennessee 38163 , United States.

出版信息

J Med Chem. 2019 Aug 8;62(15):6925-6940. doi: 10.1021/acs.jmedchem.9b00187. Epub 2019 Jul 24.

DOI:10.1021/acs.jmedchem.9b00187
PMID:31294974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8688139/
Abstract

The natural product colletoic acid (CA) is a selective inhibitor of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which primarily converts cortisone to the active glucocorticoid (GC) cortisol. Here, CA's mode of action and its potential as a chemical tool to study intracellular GC signaling in adipogenesis are disclosed. 11β-HSD1 biochemical studies of CA indicated that its functional groups at C-1, C-4, and C-9 were important for enzymatic activity; an X-ray crystal structure of 11β-HSD1 bound to CA at 2.6 Å resolution revealed the nature of those interactions, namely, a close-fitting and favorable interactions between the constrained CA spirocycle and the catalytic triad of 11β-HSD1. Structure-activity relationship studies culminated in the development of a superior CA analogue with improved target engagement. Furthermore, we demonstrate that CA selectively inhibits preadipocyte differentiation through 11β-HSD1 inhibition, suppressing other relevant key drivers of adipogenesis (i.e., PPARγ, PGC-1α), presumably by negatively modulating the glucocorticoid signaling pathway. The combined findings provide an in-depth evaluation of the mode of action of CA and its potential as a tool compound to study adipose tissue and its implications in metabolic syndrome.

摘要

天然产物 colletoic 酸(CA)是 11β-羟甾类脱氢酶 1 型(11β-HSD1)的选择性抑制剂,主要将可的松转化为活性糖皮质激素(GC)皮质醇。在这里,揭示了 CA 的作用模式及其作为研究脂肪生成中细胞内 GC 信号的化学工具的潜力。CA 的 11β-HSD1 生化研究表明,其 C-1、C-4 和 C-9 位的功能基团对酶活性很重要;与 CA 结合的 11β-HSD1 的 X 射线晶体结构分辨率为 2.6Å,揭示了这些相互作用的本质,即约束的 CA 螺环与 11β-HSD1 的催化三联体之间的紧密配合和有利相互作用。构效关系研究最终开发出了一种具有改进靶标结合的优越 CA 类似物。此外,我们证明 CA 通过抑制 11β-HSD1 选择性抑制前脂肪细胞分化,抑制脂肪生成的其他相关关键驱动因素(即 PPARγ、PGC-1α),可能通过负调控糖皮质激素信号通路。综合研究结果深入评估了 CA 的作用模式及其作为研究脂肪组织及其在代谢综合征中的意义的工具化合物的潜力。

相似文献

1
Mechanistic Insight on the Mode of Action of Colletoic Acid.关于蔻酸作用模式的机制见解。
J Med Chem. 2019 Aug 8;62(15):6925-6940. doi: 10.1021/acs.jmedchem.9b00187. Epub 2019 Jul 24.
2
Synthesis and evaluation of colletoic acid core derivatives.愈创木酸核心衍生物的合成与评价
Eur J Med Chem. 2016 Mar 3;110:126-32. doi: 10.1016/j.ejmech.2016.01.027. Epub 2016 Jan 20.
3
Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.新型选择性 11β-羟甾类脱氢酶 1 型抑制剂在饮食诱导肥胖小鼠模型中的抗糖尿病和抗脂肪生成作用。
Eur J Pharmacol. 2012 Sep 15;691(1-3):19-27. doi: 10.1016/j.ejphar.2012.06.024. Epub 2012 Jul 1.
4
The role of 11beta-hydroxysteroid dehydrogenase in metabolic disease and therapeutic potential of 11beta-hsd1 inhibitors.11β-羟基类固醇脱氢酶在代谢性疾病中的作用及11β-HSD1抑制剂的治疗潜力
Curr Med Chem. 2008;15(7):642-9. doi: 10.2174/092986708783885264.
5
A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101.一种新型高活性和选择性的 11β-羟甾脱氢酶 1 型抑制剂,INU-101。
Eur J Pharmacol. 2018 Sep 15;835:169-178. doi: 10.1016/j.ejphar.2018.08.005. Epub 2018 Aug 8.
6
Differential modulation of 3T3-L1 adipogenesis mediated by 11beta-hydroxysteroid dehydrogenase-1 levels.11β-羟基类固醇脱氢酶-1水平介导的3T3-L1脂肪生成的差异调节
J Biol Chem. 2007 Apr 13;282(15):11038-46. doi: 10.1074/jbc.M606197200. Epub 2007 Feb 20.
7
Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.通过基于配体和结构的虚拟筛选联合鉴定新型11β-羟基类固醇脱氢酶1抑制剂
Mol Cell Endocrinol. 2014 Mar 25;384(1-2):71-82. doi: 10.1016/j.mce.2014.01.011. Epub 2014 Jan 18.
8
Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes.白藜芦醇抑制大鼠脂肪微粒体 11β-羟甾类脱氢酶 1 型活性。
J Endocrinol. 2013 Aug 29;218(3):311-20. doi: 10.1530/JOE-13-0066. Print 2013 Sep.
9
Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.通过选择性抑制剂和跨物种比较揭示的1型11β-羟基类固醇脱氢酶的活性位点变异性
Mol Cell Endocrinol. 2006 Mar 27;248(1-2):26-33. doi: 10.1016/j.mce.2005.11.043. Epub 2006 Jan 20.
10
2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice.2-氨基-1,3-噻唑-4(5H)-酮作为强效和选择性11β-羟基类固醇脱氢酶1型抑制剂:酶-配体共晶体结构及在C57Bl/6小鼠中的药效学效应证明
J Med Chem. 2008 May 22;51(10):2933-43. doi: 10.1021/jm701551j. Epub 2008 Apr 18.

引用本文的文献

1
Early Preclinical Studies of Ergosterol Peroxide and Biological Evaluation of Its Derivatives.过氧化麦角甾醇的早期临床前研究及其衍生物的生物学评价
ACS Omega. 2024 Aug 19;9(35):37117-37127. doi: 10.1021/acsomega.4c04350. eCollection 2024 Sep 3.

本文引用的文献

1
Development of ergosterol peroxide probes for cellular localisation studies.过氧麦角甾醇探针的研制及其用于细胞定位研究。
Org Biomol Chem. 2019 May 29;17(21):5223-5229. doi: 10.1039/c9ob00145j.
2
A Novel F-Labeled Radioligand for Positron Emission Tomography Imaging of 11β-Hydroxysteroid Dehydrogenase (11β-HSD1): Synthesis and Preliminary Evaluation in Nonhuman Primates.一种用于正电子发射断层扫描成像的新型 F 标记放射性配体 11β-羟甾类脱氢酶(11β-HSD1):在非人灵长类动物中的合成和初步评估。
ACS Chem Neurosci. 2019 May 15;10(5):2450-2458. doi: 10.1021/acschemneuro.8b00715. Epub 2019 Feb 19.
3
Adipocyte hypertrophy-hyperplasia balance contributes to weight loss after bariatric surgery.脂肪细胞肥大-增生平衡有助于减肥手术后体重减轻。
Adipocyte. 2017 Apr 3;6(2):134-140. doi: 10.1080/21623945.2017.1287639. Epub 2017 Jan 27.
4
Counting on natural products for drug design.依靠天然产物进行药物设计。
Nat Chem. 2016 Jun;8(6):531-41. doi: 10.1038/nchem.2479. Epub 2016 Apr 25.
5
Natural Products as Sources of New Drugs from 1981 to 2014.1981年至2014年作为新药来源的天然产物
J Nat Prod. 2016 Mar 25;79(3):629-61. doi: 10.1021/acs.jnatprod.5b01055. Epub 2016 Feb 7.
6
Synthesis and evaluation of colletoic acid core derivatives.愈创木酸核心衍生物的合成与评价
Eur J Med Chem. 2016 Mar 3;110:126-32. doi: 10.1016/j.ejmech.2016.01.027. Epub 2016 Jan 20.
7
Safety, pharmacokinetics and pharmacodynamics of BI 135585, a selective 11β-hydroxysteroid dehydrogenase-1 (HSD1) inhibitor in humans: liver and adipose tissue 11β-HSD1 inhibition after acute and multiple administrations over 2 weeks.BI 135585 在人体中的安全性、药代动力学和药效学:单次和连续 2 周给药后,肝脏和脂肪组织中 11β-羟甾类脱氢酶-1(HSD1)的抑制作用。
Diabetes Obes Metab. 2016 May;18(5):483-90. doi: 10.1111/dom.12635. Epub 2016 Mar 10.
8
Regulatory Actions of Glucocorticoid Hormones: From Organisms to Mechanisms.糖皮质激素的调节作用:从生物体到作用机制
Adv Exp Med Biol. 2015;872:3-31. doi: 10.1007/978-1-4939-2895-8_1.
9
The cell biology of fat expansion.脂肪扩张的细胞生物学
J Cell Biol. 2015 Mar 2;208(5):501-12. doi: 10.1083/jcb.201409063.
10
Hupehenols A-E, selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors from Viburnum hupehense.湖北荚蒾中的湖北酚A - E,选择性11β - 羟基类固醇脱氢酶1型(11β - HSD1)抑制剂。
J Nat Prod. 2015 Feb 27;78(2):330-4. doi: 10.1021/np500896n. Epub 2015 Jan 15.